CISGENDER WOMEN
HIV diagnosis rates among women have been stable over recent years, and many are still at risk of getting HIV.*
TRANSGENDER WOMEN
*In 2022, based on data published by the Centers for Disease Control and Prevention (CDC).
†According to studies conducted between 2006 and 2017.
OF WOMEN LIVING WITH HIV, 1 IN EVERY 10 DOES NOT KNOW THEY ARE HIV POSITIVE.*
That’s why it’s so important to get tested regularly.
*In 2022, based on data published by the Centers for Disease Control and Prevention (CDC).
WHY SHOULD WOMEN USE PrEP?
When a sexy moment is heating up, things don’t always go as planned. If you are a sexually active woman, ask your doctor about PrEP, especially if you have had any of the following:
An HIV-positive sexual partner (especially if the partner has an unknown or detectable viral load)
A bacterial sexually transmitted infection (STI) in the past 6 months
A history of inconsistent or no condom use with your sexual partner(s)
A partner with an unknown HIV status
APRETUDE does not prevent other sexually transmitted infections. Practice safer sex by using a latex or polyurethane condom to reduce the risk of getting sexually transmitted infections. Talk to your doctor about PrEP options.
THERE’S A LONG-ACTING PrEP OPTION TO HELP PROTECT WOMEN FROM HIV-1
Learn about the clinical study results.
APRETUDE is given every other month by a healthcare provider after initiation injections have been given 1 month apart for 2 consecutive months. Stay under a provider’s care while receiving APRETUDE. You must receive it as scheduled. If you will miss a scheduled injection by more than 7 days, call your provider right away.
PMUS-CBTWCNT240126